---
schema_version: "secwatch.filing_event.v1"
accession: "0001906324-24-000002"
form_type: "8-K"
ticker: "QDEL"
cik: "0001906324"
company_name: "QuidelOrtho Corp"
filed_at: "2024-02-13T23:59:59+00:00"
generated_at: "2026-06-06T03:48:50.665659+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# QuidelOrtho Q4 revenue $743M (-14% YoY); GAAP EPS $0.10, adj. EPS $1.17; FY24 guidance issued

## Summary
- Q4 revenue $743M vs $867M YoY; non-respiratory +9%, respiratory -49%.
- GAAP diluted EPS $0.10 (prior $0.45); adjusted diluted EPS $1.17 (prior $1.76).
- Full-year 2023 revenue $3.0B; GAAP diluted loss $0.15; adjusted EBITDA $723M (24% margin).
- FY24 guidance: revenue $2.76-3.07B; adj. EBITDA $565-720M; adj. EPS $2.40-3.07.
- Received 510(k) for Savanna multiplex platform and CLIA waiver for Sofia 2 SARS Antigen+ FIA.

## SEC filing metadata
- accession: 0001906324-24-000002
- form_type: 8-K
- ticker: QDEL
- cik: 0001906324
- company_name: QuidelOrtho Corp
- filed_at: 2024-02-13T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1906324/000190632424000002/0001906324-24-000002-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1906324/000190632424000002/qdel-20240213.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001906324-24-000002
- JSON: https://secwatch.observer/filing/0001906324-24-000002.json
- Plain text: https://secwatch.observer/filing/0001906324-24-000002.txt

## Key facts
- Earnings Releases
  QuidelOrtho Corp updated its fourth quarter and full-year ended December 31, 2023 guidance (initiated).
  - Period: fourth quarter and full-year ended December 31, 2023
  - Guidance: initiated
  - Result: reported results
  source text: On February 13, 2024, QuidelOrtho Corporation (“QuidelOrtho”) issued a press release announcing the financial results for its fourth quarter and full year ended December 31, 2023 and will hold an earnings conference call at 2:00 p.m., Pacific Time, on February 13, 2024 to discuss such results.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1906324/000190632424000002/0001906324-24-000002-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.